Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution

Cited by (286)

Items 201–286 of 286

1. Protein State‐Dependent Chemical Biology
   Kevin A. Scott, Tiffany L. Zhang, Sarah Y. Xi, Bryan Ngo, Ekaterina V. Vinogradova · 2023 · Israel Journal of Chemistry
2. Massive Solubility Changes in Neuronal Proteins upon Simulated Traumatic Brain Injury Reveal the Role of Shockwaves in Irreversible Damage
   Amir Ata Saei, Hassan Gharibi, Hezheng Lyu, Brady Nilsson, Maryam Tayefeh Jafari, Hans von Holst, Roman A. Zubarev · 2023 · Molecules
3. Advancements in Chemical Proteomics for Target Identification of Natural Products in Live Cells
   Abid Hussain Banday, Insha Ashraf, Mudasir Bashir, Aariya Yousuf, Basit Qayoom, Mysar Ahmad Bhat, Saima Nabi, Saima Maqbool, Muzaffar A. Lone · 2024 · The Natural Products Journal
4. MSstatsTMT Improves Accuracy of Thermal Proteome Profiling
   Amanda M. Figueroa‐Navedo, Rohan Kapre, Tushita Gupta, Yingrong Xu, Clifford G. Phaneuf, Pierre M. Jean Beltran, Liang Xue, Alexander R. Ivanov, Olga Vitek A · 2025 · Molecular & Cellular Proteomics
5. Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition
   Chuwei Lin, Catherine M Sniezek, Christopher D. McGann, Rashmi Karki, Ross M. Giglio, Benjamin A. Garcia, José L. McFaline‐Figueroa, Devin K. Schweppe · 2026 · Communications Biology
6. Dihydroflavonoid glycosides from Viscum album and their inhibitory effects on hepatic lipid accumulation and target identification
   Guo‐Zhu Su, Shang-Yi Wang, Xiuying Yang, Z. D. Stevanović, Na Li, Nikola Tanić, Nebojša Arsenijević, Shi‐Shan Yu, Yong Li · 2022 · Phytochemistry
7. Analysis of Independent Differences (AID) detects complex thermal proteome profiles independent of shape and identifies candidate panobinostat targets
   Alexandra Panov, Steven P. Gygi · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
8. SIESTA as a universal unbiased proteomics approach for identification and prioritization of enzyme substrates
   Amir Ata Saei, Christian Michel Beusch, Pierre Sabatier, Juan Astorga‐Wells, Hassan Gharibi, Zhaowei Meng, Alexey L. Chernobrovkin, Sergey Rodin, Katja Näreoja, A.G. Thorsell et al. · 2021 · Research Square
9. Pharmacological PP2A reactivation overcomes multikinase inhibitor tolerance across brain tumor cell models
   Oxana V. Denisova, Joni Merisaari, Riikka Huhtaniemi, Xi Qiao, Amanpreet Kaur, Laxman Yetukuri, Mikael Jumppanen, Mirva Pääkkönen, Сarina von Schantz‐Fant, Michael H. J. Ohlmeyer et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
10. Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action
    Ritwik Maity, Xuepei Zhang, Francesca Romana Liberati, Chiara Scribani Rossi, Francesca Cutruzzolà, Serena Rinaldo, Massimiliano Gaetani, José Antonio Aínsa, Javier Sancho · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
11. Application of Whole Proteome Thermal Shift Assays to Define PERK-dependent Changes in Protein Homeostasis during the Unfolded Protein Response
    Neil A. McCracken, Sarah A. Peck Justice, Whitney R. Smith-Kinnaman, H. R. Sagara Wijeratne, Avery M. Runnebohm, S. William Pelletier, Emma H. Doud, Ronald C. Wek, Amber L. Mosley · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
12. EXOSC3 G191 Variants Trigger System-Wide Recalibration of RNA Processing Machinery
    Wijeratne, H.R. Sagara, Runnebohm, Avery M., Barron, Monica P., Hampton, Ariana J., Li, Rudong, Peck Justice, Sarah A., Lenceski, Sophia H., Rooney, James D., Smith-Kinnaman, Whitney R., Chang, Gina S. et al. · 2026
13. DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
    Ehsan Zangene, Elham Gholizadeh, Veit Schwämmle, Amir Ata Saei, Mathias Wilhelm, Lukas Käll, Mohieddin Jafari · 2026 · Molecular & Cellular Proteomics
14. Systematic Investigation of Dose-Dependent Protein Thermal Stability Changes to Uncover the Mechanisms of the Pleiotropic Effects of Metformin
    Kejun Yin, Ronghu Wu · 2024 · ACS Pharmacology & Translational Science
15. Proteome integral solubility alteration via label‐free DIA approach (PISA‐DIA), game changer in drug target deconvolution
    Zheng Ser, Radoslaw Mikolaj Sobota · 2024 · PROTEOMICS
16. Peptide-to-Protein Data Aggregation Using Fisher’s Method Improves Target Identification in Chemical Proteomics
    Hezheng Lyu, Hassan Gharibi, Zhaowei Meng, Bohdana Sokolova, Susanna Lundström, Xuepei Zhang, Roman A. Zubarev · 2026 · Analytical Chemistry
17. Systematic Characterization of Thermal Stability Assay Parameters and Application in Discovery of Peptide–Protein Interactions
    Daniel M. Richards, Fangyi Zhai, Shaoxian Li, Qing Yu · 2026 · Journal of Proteome Research
18. Hyperosmotic niche adaptation and tissue polyamines underlie MRSA persistence in the kidney
    Nobuhiro Kanazawa, Caroline P. Martens, Shinichi Makino, Segewkal Heruye, Amy Zollman, Jered Myslinski, Annabelle White, Chetan Poudel, Jodi Yanagida, Farooq Syed et al. · 2026 · Science Translational Medicine
19. ThermoTargetMiner as a proteome integral solubility alteration target database for prospective drugs against lung cancer
    Hezheng Lyu, Hassan Gharibi, Bohdana Sokolova, Mücahit Varlı, Anna Voiland, Brady Nilsson, Zhaowei Meng, Massimiliano Gaetani, Amir Ata Saei, Roman A. Zubarev · 2026 · Communications Chemistry
20. Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
    Chris S. Pridgeon, Dian Bolhuis, F. Milosavljević, M. Manojlović, Ákos Végvári, Massimiliano Gaetani, Marin M. Jukić, Magnus Ingelman‐Sundberg · 2022 · Cells
21. Identifying drug targets with thermal proteome profiling using IBT‐16plex
    Zhaomei Shi, Yan Ren, Shuwei Li, Piliang Hao · 2023 · Rapid Communications in Mass Spectrometry
22. Profiling the Misfolded Proteome in Human Disease
    Vivian C. Onwudiwe, Joseph C. Genereux · 2024 · Israel Journal of Chemistry
23. An Integral Activity-Based Protein Profiling Method for Higher Throughput Determination of Protein Target Sensitivity to Small Molecules
    Chathuri Jeewanthi Kombala Nanayakkara Thambiliya, Agne Sveistyte, Tong Zhang, Leo J. Gorham, Gerard X. Lomas, John Melchior, Priscila M. Lalli, Vanessa Paurus, Stephen Callister, Aaron Wright et al. · 2025 · ACS Chemical Biology
24. Preclinical study of cannflavins A and B action against glioblastoma cells
    Jennifer Holborn, Hannah N. Robeson, Ellis Chartley, Tiana Gluscevic, Adina Borenstein, Colby J. Perrin, Begüm Alural, Himain Perera, Tariq A. Akhtar, Nina Jones et al. · 2026 · Phytomedicine Plus
25. Neutron-activation analysis for measurement of concentration profiles in ion etching
    V.M. Tartakovskii, G.A. Vasil'ev · 1987 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
26. Proteome integral solubility alteration assay combined with multi-criteria decision-making analysis for developing adverse outcome pathways
    Verónica Lizano-Fallas, Ana Carrasco del Amor, Susana Cristóbal · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
27. A gene essentiality signature enables predicting the mechanism of action of drugs
    Wenyu Wang, Jie Bao, Shuyu Zheng, Shan Huang, Jehad Aldahdooh, Yinyin Wang, Johanna Eriksson, Ziaurrehman Tanoli, Xuepei Zhang, Massimiliano Gaetani et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
28. Maternal sterol 27-hydroxylase is crucial for securing fetal development
    Mitsuyoshi Suzuki, Satoshi Nakano, Natsumi Miharada, Hajime Takei, Pavan Prabhala, Mark van der Garde, Catharina Müller, Valgarður Sigurðsson, Aerken Maolake, Kiyoka Saito et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
29. Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action
    Ritwik Maity, Xuepei Zhang, Francesca Romana Liberati, Chiara Scribani Rossi, Francesca Cutruzzolà, Serena Rinaldo, Massimiliano Gaetani, José Antonio Aínsa, Javier Sancho · 2024 · eLife
30. Thermal proteome profiling identifies glucose binding proteins involved in metabolic disease
    Lindsey M. Meservey, Ian Ferguson, Vivian B. Tien, Luca Ducoli, Weili Miao, David M. Lu, Suhas Srinivasan, Vanessa Lopez-Pajares, Douglas F. Porter, Zhongwen Cao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
31. Discovery of Host-Directed Small Molecules with Broad Anti-Leishmanial Efficacy
    Elizabeth G. Graham-Gurysh, M. Shamim Hasan Zahid, Monica M. Johnson, Antonio Landavazo, Ojas A. Namjoshi, Joseph W. Wilson, Devika M. Varma, Ryan N. Woodring, Aaron T. Hendricksen, Joseph F. Vath et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
32. NUDT5 regulates the global efficacy of nucleoside analog drugs by coordinating purine synthesis and PRPP allocation
    Nicholas C.K. Valerie, Seher Alam, Femke M. Hormann, Ulf Märtens, Bo Lundgren, Massimiliano Gaetani, Johan Boström, Sean G. Rudd, Per I. Arvidsson, Mikael Altun · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
33. A Chemical Inducer of Ribophagy Limits the Toxicity of ALS-Related Arginine-Rich Peptides
    Bartłomiej Porębski, Vanesa Lafarga, Catherine S. Hansel, Martin Haraldsson, Anabel Sáez-Mas, Ángela Sánchez-Molleda, Saioa Moragón, Maria Häggblad, Louise Lidemalm, Sara Rodrigo et al. · 2026 · SSRN Electronic Journal
34. Experiences in Academic and Industry Partnerships – Forging a Path to Translational Drug Discovery
    Roland E. Dolle, Denise V. Barrault, Neil O. Carragher, Paul D. Andrews, Daniel V. Ebner, Andrew Hopkins, Hirotatsu Kojima, Stephen V. Frye, Al Edwards, Peter I. Dosa et al. · 2021 · Burger's Medicinal Chemistry and Drug Discovery
35. Small molecule inhibition of multiple RNA binding proteins underlies Musashi-2 independent phenotypes
    Kathryn Walters, Marcin Piotr Sajek, Aaron Issaian, Amber Baldwin, Evan Harrison, Elisabeth Murphy, Miles Daniels, Julie A Reisz Haines, Kirk Charles Hansen, Angelo D’Alessandro et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
36. Lineage-specific oncogenes drive growth of major forms of human cancer using common downstream mechanisms
    Otto Kauko, Mikko M. Turunen, Päivi Pihlajamaa, Antti Häkkinen, Rayner M. L. Queiroz, Mirva Pääkkönen, Sami Ventelä, Massimiliano Gaetani, Susanna L. Lundström, Antonio Murgia et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
37. Toxicoproteomics, from finding molecular targets to evaluating the impact on human health
    Verónica Lizano-Fallas · 2023 · Linköping University medical dissertations
38. Fully automated and integrated proteomics sample preparation platform for high-throughput drug target identification
    Qiong Di Wu, Jiangnan Zheng, Xintong Sui, Changying Fu, Xiaozhen Cui, Bin Yih Liao, Hongchao Ji, Yang Luo, An He, Xue Mei Lu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
39. Chemogenetic inhibition of IST1-CHMP1B interaction impairs endosomal recycling and promotes unconventional LC3 lipidation at stalled endosomes
    Anastasia Knyazeva, Shuang Li, Dale Corkery, Kasturika Shankar, Laura K. Herzog, Xuepei Zhang, Birendra Singh, Georg Niggemeyer, David Grill, Jonathan D. Gilthorpe et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
40. Assessment of Rocaglates and Targeted Derivatives as Selective Inhibitors of Glioblastoma Stem Cells
    Zihao Wang, Ritesh Thakare, Shalaka Chitale, Alok Mishra, Stanley I. Goldstein, Alice C. Fan, Rui Li, Lihua Julie Zhu, Lauren E. Brown, Michael R. Green et al. · 2023 · SSRN Electronic Journal
41. Chloroplastic ascorbate acts as a regulatory hub in plant metabolism regardless of oxidative stress
    Dávid Tóth, Roland Tengölics, Fayezeh Aarabi, Anna Karlsson, André Vidal‐Meireles, László Kovács, Soujanya Kuntam, Tímea Körmöczi, Alisdair Robert Fernie, Elton Paul Hudson et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
42. Development and evaluation of data analysis approaches to increase the specificity and performance of thermal shift assays for assessment of protein-small molecule interactions
    Amanda M. Figueroa‐Navedo · 2023
43. Development of improved drug-target profiling methods using mass spectrometry-based thermal stability assays
    Clifford G. Phaneuf · 2023
44. Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action
    Ritwik Maity, Xuepei Zhang, Francesca Romana Liberati, Chiara Scribani Rossi, Francesca Cutruzzolà, Serena Rinaldo, Massimiliano Gaetani, José Antonio Aínsa, Javier Sancho · 2024 · eLife
45. Author response: Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action
    Ritwik Maity, Xuepei Zhang, Francesca Romana Liberati, Chiara Scribani Rossi, Francesca Cutruzzolà, Serena Rinaldo, Massimiliano Gaetani, José Antonio Aínsa, Javier Sancho · 2024 · eLife
46. Reviewer #1 (Public Review): Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action
    2024 · eLife
47. One-Pot Time-Induced Proteome Integral Solubility Alteration (OPTI-PISA) assay for automated and sensitive drug target identification
    Zhaowei Meng, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Roman A. Zubarev · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
48. Emerging Technologies for Epigenetic Drug Discovery
    2024 · Royal Society of Chemistry eBooks
49. Mass Spectrometry and Chemical Biology Approaches for Deconvoluting Epigenetic Targets
    Antony J. Burton, Ghaith M. Hamza, Anthony A. Iannetta, Eric Miele, Andrew X. Zhang · 2024 · Royal Society of Chemistry eBooks
50. PEBP1 amplifies mitochondrial dysfunction induced integrated stress response
    Ling Cheng, Ian Timothy Sembiring Meliala, Yidi Kong, Jingyuan Chen, Christopher G. Proud, Mikael Björklund · 2024 · eLife
51. TargetSeeker-MS: A Bayesian Inference Approach for Drug–Target Discovery Using Protein Fractionation Coupled to Mass Spectrometry
    Mathieu Lavallée‐Adam, Alexander R. Pelletier, Jolene K. Diedrich, Antônio F. M. Pinto, Salvador Martínez‐Bartolomé, Michael Petrascheck, James J. Moresco, John R. Yates · 2025 · Journal of the American Society for Mass Spectrometry
52. Phenotypic drug discovery
    Sonja Sievers, Herbert Waldmann, Slava Ziegler · 2025 · Elsevier eBooks
53. Mechanistic Insights into TYSM Protein Regulation by mTORC2 in Response to Chemotherapy
    Abdulrahman El Sayed, Maciej Zakrzewski, Remigiusz Adam Serwa, Abdelhalim Azzi · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
54. Deconvolution of the on-target activity of plasmepsin V peptidomimetics in P. falciparum parasites
    Wenyin Su, William Nguyen, Ghizal Siddiqui, Jerzy Michal Dziekan, Danushka S. Marapana, Jocelyn Sietsma Penington, Somya Mehra, Zahra Razook, Kirsty McCann, Anna Ngo et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
55. Integral Synthesis and Clearance Analysis via DIA (ISDia) Reveals Diverse Protein Abundance Regulation during Endoplasmic Reticulum Stress
    Yue Dou, Danny Qiu, Vivien Li, Maja Wierzbinska, Gregory R. Keele, Wenpeng Liu, Jie Yang, João A. Paulo, Ling Qi, Tian Zhang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
56. Metabolite Functions Revealed by Mass Spectrometry-Based Target Engagement Proteomics Approaches
    Nisha A. Owens, Tayah B. Sommer, Brenna G. Ing, Mukhayyo Sultonova, John Patrick Murphy · 2025 · Journal of Proteome Research
57. Proteome integral solubility alteration assay for monitoring antibody-antigen cell interactions
    Weiqi Lu, Susanna L. Lundström, Yaolin Hou, Sourav Mukherjee, Jesper Z. Haeggström, Massimiliano Gaetani, Roman A. Zubarev · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
58. Proteome-Wide Monitoring of Drug Action in Living Cells Using a Novel Label-Free Solvent-Based Shift Assay
    Dominik Steinbrunn, Catalina Cepeleaga, Alexander Betz, Gözde Kibar, Melanie Holzner, Stefan K. Maier, Christin Zasada, Götz Hagemann, Stephan A. Sieber, Hannes Hahne · 2025 · Molecular & Cellular Proteomics
59. DrPISA: Deep eutectic solvent-assisted reverse proteome-integrated solubility alteration for high-sensitivity drug target identification
    Liu Yang, Tian-Bo Ma, Chen-Wan Guo, Run-Bo Yu, Ping Li, Hua Yang, Wen Gao · 2026 · Analytica Chimica Acta
60. Exploring infection biology with mass spectrometry-based proteomics
    Grisna Isabel Prensa, Andrea García Navarro, David Parker, Andrea Fossati · 2026 · Molecular Omics
61. A systemic circadian nicotinic acid riboside (NaR) signal engages the unfolded protein response and adipogenesis via the prefoldin complex
    Ivan Vlassakev, Christina Savva, Liying Zhou, Danilo Ritz, Alexander Schmidt, Cholsoon Jang, Amir Ata Saei, Paul Petrus · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
62. Proteomic profiling reveals pleiotropic antimetabolite activity of triciribine in acute lymphoblastic leukemia
    Xuekang Qi, Georgios Mermelekas, Ondřej Hodek, Luay Aswad, Quentin Glaziou, Isabelle Rose Leo, Nona Struyf, Ioannis Siavelis, Henri Colyn Bwanika, Owen F.J. Hovey et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
63. SP3-PELSA: A rapid and sensitive approach for studying protein-ligand interaction with small-amount samples
    Jiaqin Chen, Guangxu Hu, Jie Song, Lin Huang, Xumin Zhang · 2026 · Analytica Chimica Acta
64. Label-Free Target Discovery Strategy for Natural Active Products
    Lei Shan, Yujia Chen, Xiuling Cao, Xuejiao Jin, Beidong Liu · 2026 · Biomolecules
65. Étude de la restauration de la réponse immunitaire antitumorale dans un modèle murin de cancer pulmonaire induit par une molécule multicible inhibitrice de HDAC et du splicéosome
    Sarah Ducellier · 2023
66. Lysosomal accumulation of masitinib alters autophagy via pH-dependent trapping
    Abdulrahman El Sayed, Monika Kluzek, Remigiusz Adam Serwa, Abdelhalim Azzi · 2026 · European Journal of Pharmacology
67. A ginsenoside metabolite and its derivative target PRELID3B against lung cancer cells
    Jilin He, Chun‐Nam Lok, Guanya Yang, Ying He, Yungen Liu, Amir Ata Saei, Yiwei Zhang, Chunlei Zhang, Yanting Zhu, Zhiwen Fu et al. · 2026 · Proceedings of the National Academy of Sciences
68. Transcriptomic-guided compound prioritization and proteomics validation for HNRNPU deficiency identify signalling correction
    Xuan Ye, Diana Tikhomirova, Marika Oksanen, Massimiliano Gaetani, Hassan Gharibi, Francesca Mastropasqua, Kristiina Tammimies · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
69. Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer
    Liang Sun, Sang Ah Yi, Brittany Q Pham, Antoine Mocellin, Sagnik Sen, M. Jason de la Cruz, Alban Ordureau, Heeseon An · 2026 · Journal of the American Chemical Society
70. Cell painting and thermal proteome profiling for inference of drug targets and mechanism of action
    Camilla Johansson, Martin Johansson, Phanindra Babu Kasi, Mårten Larsson, Per‐Johan Jakobsson, Ulf Göransson, Jordi Carreras Puigvert, Ola Spjuth, Erik T. Jansson · 2026 · Molecular Systems Biology
71. A Miniaturized, Automated Proteomic Sample Preparation Platform for High-Throughput Target Deconvolution of Natural Products
    Qiong Wu, Yue Lin, J S Chen, Bin Liao, Xianjie Qiu, Yongzhi Lu, Shuangtong Xi, Minxian Dai, Kunzhong Wu, Wenhua Li et al. · 2026 · Analytical Chemistry
72. Detergent selection as a determinant of protein melting behavior and drug-target interaction-calling in thermal stability proteomics
    Catherine M Sniezek, Veronika A. Glukhova, Christopher Schmitz, Katarina Vlajic, Devin K. Schweppe · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
73. Temperature Range Thermal Proteome Profiling for Drug Target Identification: A Practical Guide
    Yi Xue, Peiyu Chen, Meining Xing, Lifeng Han, Wantao Ying · 2026 · Journal of Proteome Research
74. Drugging the proteome via large-scale chemoproteomics.
    Yushu Li, Jiaqi Wang, Tiantian Wang, Xisong Ke, Yi Qu · 2026 · TIBS -Trends in Biochemical Sciences. Regular ed
75. Synthesis and preliminary evaluation of novel compounds that demonstrate broad host-directed anti-leishmanial activity
    Elizabeth G. Graham-Gurysh, M. Shamim Hasan Zahid, Monica M. Johnson, Antonio Landavazo, Ojas A. Namjoshi, Joseph W. Wilson, Devika M. Varma, Ryan N. Woodring, Aaron T. Hendricksen, Alexandra M. Lopez et al. · 2026 · PLoS neglected tropical diseases
76. Gene Families, Structural and Functional Contexts Shape Protein Thermostability and Paralog Divergence in Arabidopsis
    Yanli Cheng, Wenqing Zhang, Feng Sun, Zhitao Hu, Zongbo Han, Junlong Zhou, Haining Dong, Weizhong Liu, Wenqing Shi · 2026 · Plants
77. A Draft Map of E. coli Proteoforms
    Jorge A. Colón-Rosado, Fei Fang, Liangliang Sun · 2026 · Analytical Chemistry
78. Target Nomination Is Not Target Validation: A Causal Evidence Architecture for Connecting Natural-Product Perturbations, Omics Signatures, Binding Evidence, and Phenotypic Rescue
    Nora Schneider, Tobias Frank, Andreas Müller, Christoph Meier · 2026 · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology
79. Decoding the Cellular Response to Methylthioadenosine Uncovers Novel Targets for Chronic Liver Disease
    Irene Blázquez‐García, Laura Guerrero, Mary Dayne S. Tai, Américo Cerqueira, Ana Cuervo, Alberto Paradela, Fernando José Corrales · 2026 · Cells
80. A Practical Guide to Dereplication in Natural Products Metabolomics
    J.‐I. Jin, Neha Garg · 2026 · Journal of Natural Products
81. Proteomics as an emerging tool for understanding biotransformation and toxicological impacts of contaminants
    Simon Klaes, Yu Liu, Marta Markiewicz, A.M. Edwards, Lorenz Adrian, Stefan Stolte, Chang Ding · 2026 · Journal of Hazardous Materials
82. A systemic circadian nicotinic acid riboside (NaR) signal engages the unfolded protein response and adipogenesis via the prefoldin complex
    Ivan Vlassakev, Christina Savva, Liying Zhou, Danilo Ritz, Alexander Schmidt, Cholsoon Jang, Amir Ata Saei, Paul Petrus · 2026 · Cell Reports
83. Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia
    Xuekang Qi, Georgios Mermelekas, Ondřej Hodek, Luay Aswad, Quentin Glaziou, Isabelle Rose Leo, Nona Struyf, Femke M. Hormann, Ioannis Siavelis, Henri Colyn Bwanika et al. · 2026 · npj Precision Oncology
84. Carbon-driven rewiring of chloroplast-mitochondrial electron transport enables energy-limited antibiotic biodegradation in phytoplankton
    Jiu-Qiang Xiong, Jia-Min Xu, Jingyu Qin, Chujin Ruan, Shujuan Zhang · 2026 · Cell Reports Sustainability
85. Screening and identification of halofuginone direct binding target proteins based on thermal proteomics profiling
    Yingcan Cui, Yihan Wang, Xiaoyang Wang, Chenzhong Fei, Chunmei Wang, Zonghui Ma, Wenchong Ye, Wen Zhou, Donghai Zhou, Zhiting Guo et al. · 2026 · Journal of Proteomics
86. Proteomic Technologies for Decoding Drug-Protein Interactions in Living Cells
    Ting YU, Mingliang YE · 2026 · Analysis and Testing Technology and Instruments